Pwbio

Pathway Bio operates a functional precision medicine platform to guide cancer treatment decisions for individual patients. The company integrates multiomic profiling and AI prediction with ex vivo microcancer technology to validate therapies against a patient's own tumor before administration. This process delivers faster, data-driven therapy recommendations to clinicians, improving outcomes for complex cancers.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

Pathway Bio operates a functional precision medicine platform to guide cancer treatment decisions for individual patients. The company integrates multiomic profiling and AI prediction with ex vivo microcancer technology to validate therapies against a patient's own tumor before administration. This process delivers faster, data-driven therapy recommendations to clinicians, improving outcomes for complex cancers.